Yayınlar & Eserler

Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study

Hizal M., BİLGİN B., Paksoy N., Kilickap S., Atci M. M., Kahraman S., et al.
FUTURE ONCOLOGY , sa.23, ss.2573-2582, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer

Dinc N. S., Aydin K., Odabas H., Ercelep O., Tufan G., ŞEKER M., et al.
ONCOLOGY RESEARCH AND TREATMENT , cilt.39, sa.3, ss.130-134, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier identifier

Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis

Genestreti G., Tiseo M., Kenmotsu H., Kazushige W., Di Battista M., Cavallo G., et al.
CLINICAL LUNG CANCER , cilt.16, sa.6, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier identifier

Clinical Outcome of Turkish Metastatic Breast Cancer Patients with Currently Available Treatment Modalities - Single Center Experience

Cabuk D., BAŞARAN G., Teomete M., Dane F., Korkmaz T., Seber S., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.1, ss.117-122, 2014 (SCI-Expanded) identifier identifier identifier identifier

Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

Korkmaz T., Seber S., KEFELİ U., Sari E., Canhoroz M., Oven B., et al.
CLINICAL & TRANSLATIONAL ONCOLOGY , cilt.15, sa.7, ss.535-540, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier identifier

Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer

Korkmaz T., Seber S., Okutur K., BAŞARAN G., Yumuk F., Dane F., et al.
BIOMARKERS , cilt.18, sa.1, ss.88-94, 2013 (SCI-Expanded) identifier identifier identifier identifier

Clinical outcome of breast cancer patients with N3a (>= 10 positive lymph nodes) disease: has it changed over years?

BAŞARAN G., Devrim C., Caglar H. B., GÜLLÜOĞLU M. B., KAYA H., Seber S., et al.
MEDICAL ONCOLOGY , cilt.28, sa.3, ss.726-732, 2011 (SCI-Expanded) identifier identifier identifier identifier
Diğer Dergilerde Yayınlanan Makaleler

Prevalence of K-Ras mutations in hepatocellular carcinoma: A Turkish Oncology Group pilot study

Turhal N. S., SAVAŞ B., COŞKUN Ö., Bas E., Karabulut B., Nart D., et al.
MOLECULAR AND CLINICAL ONCOLOGY , sa.6, ss.1275-1279, 2015 (ESCI) Creative Commons License Sürdürülebilir Kalkınma identifier identifier
Metrikler

Yayın

43

Atıf (WoS)

251

H-İndeks (WoS)

10

Atıf (Scopus)

217

H-İndeks (Scopus)

9

H-İndeks (Scholar)

1

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

2

Proje

1

Açık Erişim

6
BM Sürdürülebilir Kalkınma Amaçları